home

LATEST ONCOPRESCRIBE UPDATES

• FDA Grants Regular Approval to TRODELVY® for Advanced Triple Negative Breast Cancer

• Prostate Cancer Risk Associated with Familial and Hereditary Cancer Syndromes

• Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline

• FDA Approves SARCLISA® Combination for Relapsed or Refractory Myeloma

SHOW MORE

FDA
Approvals

Meeting
Updates

Hem/Onc
Updates

Symptom
Management

NEW REGIMENS ADDED

Research Regimens

• OPDIVO® and YERVOY® - for Malignant Melanoma

• OPDIVO® and YERVOY® - for Non Small Cell Lung Cancer

• OPDIVO® and YERVOY® with Limited Course Chemotherapy - for Non Small Cell Lung Cancer (Adenocarcinoma)

• Single Agent PEMAZYRE® - for Cholangiocarcinoma

• PARAPLATIN® and VEPESID® with IMFINZI® - for Small Cell Lung Cancer

Curbside Consultation

Breast Cancer Special Issue

Immuno-Oncology

Precision Oncology

• COVID-19 Associated Coagulopathy: Diagnosis and Management
  

• Dual Inhibition Improves Outcomes for Patients with BRAF-Mutated Colorectal Tumors
  

SHOW MORE